“Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC)”, J of Skin, vol. 6, no. 6, p. s96, Nov. 2022, doi: 10.25251/skin.6.supp.96.